K800514 is an FDA 510(k) clearance for the PHENCYCLIDINE DIRECT BLOOD RIA KIT. Classified as Radioimmunoassay, Phencyclidine (product code LCL).
Submitted by Immunalysis Corporation (Walker, US). The FDA issued a Cleared decision on March 19, 1980 after a review of 14 days - a notably fast clearance cycle.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Immunalysis Corporation devices